SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 405 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $3,006,320 | +18.1% | 23,222 | -12.0% | 0.02% | +7.1% |
| Q4 2023 | $2,544,595 | -58.4% | 26,388 | -47.7% | 0.01% | -62.2% |
| Q3 2023 | $6,117,246 | +73.1% | 50,464 | +63.5% | 0.04% | +68.2% |
| Q2 2023 | $3,533,629 | -15.9% | 30,856 | +1.3% | 0.02% | -15.4% |
| Q1 2023 | $4,199,680 | -44.1% | 30,470 | -47.4% | 0.03% | -36.6% |
| Q4 2022 | $7,507,217 | -31.0% | 57,935 | -41.1% | 0.04% | -25.5% |
| Q3 2022 | $10,878,000 | +15.6% | 98,408 | -21.6% | 0.06% | +37.5% |
| Q2 2022 | $9,409,000 | +2651.2% | 125,518 | +2769.6% | 0.04% | +3900.0% |
| Q1 2022 | $342,000 | +14.8% | 4,374 | +14.0% | 0.00% | -50.0% |
| Q2 2021 | $298,000 | -5.1% | 3,838 | -8.8% | 0.00% | -33.3% |
| Q1 2021 | $314,000 | – | 4,208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |